Etanercept for refractory asthma therapy

被引:9
作者
Antoniu, Sabina A. [1 ]
机构
[1] Clin Pulm Dis, Iasi 700115, Romania
关键词
etanercept; refractory asthma; TNF-alpha;
D O I
10.1517/13543784.15.10.1279
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Asthma is a chronic disease of the airways in which inflammation causes bronchial hyper-reactivity and consequent asthma attacks triggered by various stimuli. The bronchospasm attacks are usually relieved by short-acting beta(2) agonists, and inflammation and bronchial hyper-reactivity are reduced by maintenance therapy and, in particular, by inhaled corticosteroids. In milder asthma subjects, airway inflammation is dominated by eosinophils, whereas in more severe asthma increased neutrophil counts were detected. In severe/refractory asthma, TNF-alpha is known to play a role in the maintenance of neutrophilic inflammation and of bronchial hyper-responsiveness and is not influenced by corticosteroid therapy. Etanercept, a TNF-alpha-blocking agent, could represent one of the potential therapies for refractory asthma based on demonstrated safety and efficacy.
引用
收藏
页码:1279 / 1281
页数:3
相关论文
共 11 条
[1]   Activation of tumor necrosis factor receptor 1 in airway smooth muscle: A potential pathway that modulates bronchial hyper-responsiveness in asthma? [J].
Amrani Y. ;
Chen H. ;
Panettieri Jr. R.A. .
Respiratory Research, 2000, 1 (1) :49-53
[2]   Evidence of a role of tumor necrosis factor α in refractory asthma [J].
Berry, MA ;
Hargadon, B ;
Shelley, M ;
Parker, D ;
Shaw, DE ;
Green, RH ;
Bradding, P ;
Brightling, CE ;
Wardlaw, AJ ;
Pavord, ID .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (07) :697-708
[3]   Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen challenge [J].
Bodey, KJ ;
Semper, AE ;
Redington, AE ;
Madden, J ;
Teran, LM ;
Holgate, ST ;
Frew, AJ .
ALLERGY, 1999, 54 (10) :1083-1093
[4]   INCREASED SECRETION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 BY ALVEOLAR MACROPHAGES CONSECUTIVE TO THE DEVELOPMENT OF THE LATE ASTHMATIC REACTION [J].
GOSSET, P ;
TSICOPOULOS, A ;
WALLAERT, B ;
VANNIMENUS, C ;
JOSEPH, M ;
TONNEL, AB ;
CAPRON, A .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (04) :561-571
[5]   Tumour necrosis factor (TNFα) as a novel therapeutic target in symptomatic corticosteroid dependent asthma [J].
Howarth, PH ;
Babu, KS ;
Arshad, HS ;
Lau, L ;
Buckley, M ;
McConnell, W ;
Beckett, P ;
Al Ali, M ;
Chauhan, A ;
Wilson, SJ ;
Reynolds, A ;
Davies, DE ;
Holgate, ST .
THORAX, 2005, 60 (12) :1012-1018
[6]   Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation [J].
Ohkawara, Y ;
Lei, XF ;
Stampfli, MR ;
Marshall, JS ;
Xing, Z ;
Jordana, M .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 16 (05) :510-520
[7]   TNF-α as a promising therapeutic target in chronic asthma:: a lesson from rheumatoid arthritis [J].
Russo, C ;
Polosa, R .
CLINICAL SCIENCE, 2005, 109 (02) :135-142
[8]   Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma [J].
Thomas, PS ;
Heywood, G .
THORAX, 2002, 57 (09) :774-778
[9]  
Waserman S, 2000, Can Respir J, V7, P229
[10]   Bronchoscopic evaluation of severe asthma - Persistent inflammation associated with high dose glucocorticoids [J].
Wenzel, SE ;
Szefler, SJ ;
Leung, DYM ;
Sloan, SI ;
Rex, MD ;
Martin, RJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (03) :737-743